Recurrent Glioblastoma-Molecular Underpinnings and Evolving Treatment Paradigms
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Recurrent glioblastoma (GBM) presents challenges due to molecular changes and tumor microenvironment. Emerging therapies offer new hope for managing this aggressive brain cancer.
Area Of Science
- Neuro-oncology
- Cancer Biology
- Molecular Medicine
Background
- Glioblastoma (GBM) is a highly aggressive brain tumor with poor prognosis.
- Recurrence is common despite standard treatments like surgery, radiation, and chemotherapy.
- Understanding recurrence mechanisms is crucial for developing effective therapies.
Purpose Of The Study
- To review recent molecular discoveries driving glioblastoma recurrence.
- To discuss the controversial role of surgery in recurrent GBM.
- To highlight novel and emerging treatment strategies for recurrent glioblastoma.
Main Methods
- Literature review of molecular mechanisms in GBM recurrence.
- Analysis of current evidence on surgical interventions for recurrent GBM.
- Survey of innovative therapeutic approaches including immunotherapy and targeted therapies.
Main Results
- Aberrant molecular pathways, tumor microenvironment, and epigenetics contribute to GBM recurrence.
- Surgery for recurrent GBM shows potential benefits but remains debated.
- Promising novel treatments include checkpoint inhibitors, CAR T-cell therapy, and oncolytic virotherapy.
Conclusions
- Glioblastoma recurrence is complex, involving multiple biological factors.
- The role of surgery in recurrent GBM requires further investigation.
- Innovative therapies hold significant promise for improving outcomes in recurrent glioblastoma.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
